Lv41
780 积分 2024-08-15 加入
Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma
1年前
已完结
Development and Validation of a Tool to Identify Patients Diagnosed With Castration-Resistant Prostate Cancer
1年前
已完结
PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704)
1年前
已关闭
417 Phase 3 study of pembrolizumab + belzutifan + lenvatinib or pembrolizumab/quavonlimab + lenvatinib versus pembrolizumab + lenvatinib as first-line treatment for advanced renal cell carcinoma
1年前
已关闭
Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial
1年前
已完结
Molecular subtypes as potential biomarkers in renal cell carcinoma
1年前
已完结
From biology to the clinic - exploring liver metastasis in prostate cancer
1年前
已完结
皖公网安备34019202002308
